| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC3920 |
| Trial ID | NCT06475495 |
| Disease | Rheumatoid Arthritis |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | KYV-101 |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis. Two-stage Interventional, Prospective, Randomized, Controlled, Open Label, Parallel-group Phase I/II Trial in Patients With Active, ACPA-positive and Treatment Refractory Rheumatoid Arthritis |
| Year | 2024 |
| Country | Germany |
| Company sponsor | Charite University, Berlin, Germany |
| Other ID(s) | CCM-RNT-202401|2024-514955-13-00 |
| Cohort 1 | |||||||||
|
|||||||||